Skip to main content
All lobbying filings

MILLER STRATEGIES, LLC

Lobbying for ULTRAGENYX PHARMACEUTICAL INC. · Biopharmaceutical company focused on developing novel therapies for rare genetic diseases

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · California · posted Apr 20, 2026

Official filing document

 Lobbying activity 1
Medical/Disease Research/Clinical Labs

Issues relating to rare disease and patient access.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem